REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Vaistines Vaistu Pasaulis (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: UAB Vaistines Vaistu Pasaulis Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Vaistines Vaistu Pasaulis is an enterprise based in Lithuania. Its main office is in Visaginas. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on June 26, 2000. 17 (2025) employees currently work for UAB Vaistines Vaistu Pasaulis. The company’s latest financial report indicates a net sales revenue increase of 8.63% in 2024. UAB Vaistines Vaistu Pasaulis’s net profit margin decreased by 1.29% in 2024.

Headquarters
Taikos pr. 80A
Visaginas; Utena county; Postal Code: LT-31214

Contact Details: Purchase the UAB Vaistines Vaistu Pasaulis report to view the information.

Basic Information
Total Employees:
Purchase the UAB Vaistines Vaistu Pasaulis report to view the information.
Registered Capital:
Purchase the UAB Vaistines Vaistu Pasaulis report to view the information.
Financial Auditors:
Purchase the UAB Vaistines Vaistu Pasaulis report to view the information.
Incorporation Date:
June 26, 2000
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Vaistines Vaistu Pasaulis report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.63%
Total operating revenue
8.63%
Net Profit (Loss) for the Period
-26.11%
Total equity
15.79%
Net Profit Margin
-1.29%
Return on Equity (ROE)
-7.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?